Obesity

Clinical obesity phenotypes among older adults: prevalence, determinants, and morbidity burden from the Longitudinal Ageing Study in India

Int J Obes (Lond)Published Cross-sectional study

Authors' conclusion

A substantial proportion of older adults in India had preclinical or clinical obesity, particularly women, urban residents, socioeconomically advantaged groups, and socially isolated individuals.

Study context

Population
Adults aged ≥45 years, Longitudinal Ageing Study in India (LASI, Wave 1); classified by 2025 Lancet consensus framework using Asian-specific BMI and waist circumference thresholds with physician-diagnosed conditionsLASI Wave 1
Participants
60,640 adults
Exposure
Without obesity vs Preclinical obesity vs Clinical obesity
Outcome
Prevalence of preclinical and clinical obesity
Methodological detailsnational scale, Asian-specific BMI and waist circumference thresholds, multivariable regression
  • National scale
  • Asian-specific BMI and waist circumference thresholds
  • Multivariable regression

Main finding

As reported in the abstract

Prevalence of obesity phenotypes
Preclinical or clinical obesity
37.53%

Observational data: associations, not effects.

Further findings

Determinants of higher odds of increasing obesity category

Women
AOR = 1.97
Urban residents
AOR = 1.88
Richest MPCE quintile
AOR = 1.91
Socially isolated
AOR = 1.44
Aged ≥70 years (lower odds)
AOR = 0.80
  • Fully adjusted model

Morbidity burden

Preclinical or clinical obesity vs without obesity: higher prevalence of hypertension, diabetes, chronic heart disease, chronic bone or joint disease, high cholesterol and multimorbidity

Original publication

Clinical obesity phenotypes among older adults: prevalence, determinants, and morbidity burden from the Longitudinal Ageing Study in India. Int J Obes (Lond). Published 22 September 2026. doi:10.1038/s41366-026-02226-9

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.